Özderya Ahmet, Yerlikaya Murat G, Aslan Ahmet O, Konuş Ali H, Şahin Sinan, Karal Hüseyin, Korkmaz Hatice A A, Sayın Muhammet R, Akyüz Ali R
Cardiology Clinic, Trabzon Kanuni Training and Research Hospital, Trabzon, Turkey.
Department of Cardiology, University of Health Sciences, Trabzon Ahi Evren Cardiovascular and Thoracic Surgery Training and Research Hospital, Trabzon, Turkey.
Postepy Kardiol Interwencyjnej. 2024 Sep;20(3):319-328. doi: 10.5114/aic.2024.142236. Epub 2024 Aug 13.
One of the predictable and preventable complications that may occur after transaortic valve implantation (TAVI) is the requirement for permanent pacemaker (PPM) implantation.
To evaluate the relationship between aortic knob calcification (AKC) assessed by preoperative chest X-ray and the requirement for post-procedure PPM implantation for patients who underwent TAVI.
This study was conducted with 110 patients who underwent TAVI with a Myval transcatheter heart valve in our center between June 2020 and December 2022. The patients' electrocardiograms were monitored after the procedure. The patients were evaluated in two groups according to whether they required PPM. The AKC grading was performed by examining the routine posterior-anterior chest radiographs of all patients participating in the study.
A PPM was placed in 17 (15.4%) patients after TAVI. The remaining 93 patients formed the control group. AKC ( = 0.002) and membranous septum ( = 0.013) statistically significantly differed between the PPM and control groups; however, no significant difference was detected in relation to the other parameters. In the univariable ( = 0.004) and multivariable ( = 0.024) regression analyses performed to identify predictors of PPM requirement after TAVI, AKC was found to be both a dependent and independent predictor.
AKC can be used as a cost-effective and easily accessible parameter for predicting the post-procedure PPM requirement in patients who have undergone TAVI.
经导管主动脉瓣植入术(TAVI)后可能出现的可预测和可预防的并发症之一是需要植入永久性起搏器(PPM)。
评估术前胸部X线评估的主动脉结钙化(AKC)与接受TAVI的患者术后PPM植入需求之间的关系。
本研究纳入了2020年6月至2022年12月期间在我们中心接受Myval经导管心脏瓣膜TAVI治疗的110例患者。术后对患者的心电图进行监测。根据患者是否需要PPM将其分为两组进行评估。通过检查参与研究的所有患者的常规后前位胸部X线片进行AKC分级。
TAVI术后17例(15.4%)患者植入了PPM。其余93例患者组成对照组。PPM组和对照组之间的AKC(P = 0.002)和膜性间隔(P = 0.013)在统计学上有显著差异;然而,在其他参数方面未检测到显著差异。在为确定TAVI术后PPM需求的预测因素而进行的单变量(P = 0.004)和多变量(P = 0.024)回归分析中,发现AKC既是一个相关预测因素也是一个独立预测因素。
AKC可作为预测接受TAVI的患者术后PPM需求的一个具有成本效益且易于获取的参数。